Trusted Expert Advice (TEA)

Partner with Experts in Immunogenicity Strategy.

Introducing Trusted Expert Advice (TEA), a personalized consulting service designed to support growing biotech companies navigating the complex world of immunogenicity risk strategy.

Through one-on-one consultations, TEA offers a collaborative partnership that leverages decades of experience in pre-clinical and clinical immunogenicity risk strategies. Our seasoned consultants possess a profound understanding of regulatory agency requirements and are able to provide tailored recommendations and assistance to enhance your biologic therapeutic pipeline and mitigate clinical failure risks.

Partner with EpiVax to confidently advance your biotech innovations and achieve your next milestones with expert guidance.

An immunogenicity consultant and drug developer.

TEA consultants deliver insights to give your pipeline

a competitive edge at every step of the preclinical development journey: 

R

Simplify lead candidate selection: Receive guidance in ranking candidates, allowing you to prioritize the best options for further development. 

R

Focus deimmunization and optimization: Identify critical protein regions, enabling you to optimize therapeutic design and reduce immunogenicity risk. 

R

Maximize R&D efficiency: By minimizing the need for costly downstream studies, TEA consultants help you save resources in the future — on average, 20-fold. 

RSupport strategic planning and fundraising: Reliable immunogenicity data bolsters grant applications, publications, investor materials internal product characterization discussions.

Partner with experts in immunogenicity strategy:

learn more about TEA.